133 related articles for article (PubMed ID: 38185344)
1. Dynamic changes in mitral valve extracellular matrix, tissue mechanics and function in a mouse model of Marfan syndrome.
Gonzalez BA; Harmeyer SW; Song T; Sadayappan S; Yutzey KE
Matrix Biol; 2024 Feb; 126():1-13. PubMed ID: 38185344
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE
Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435
[TBL] [Abstract][Full Text] [Related]
3. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin A; Moore V; James JM; Yutzey KE
Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm.
Pedroza AJ; Tashima Y; Shad R; Cheng P; Wirka R; Churovich S; Nakamura K; Yokoyama N; Cui JZ; Iosef C; Hiesinger W; Quertermous T; Fischbein MP
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2195-2211. PubMed ID: 32698686
[TBL] [Abstract][Full Text] [Related]
5. Smooth Muscle α-Actin Expression in Mitral Valve Interstitial Cells is Important for Mediating Extracellular Matrix Remodeling.
Dye BK; Butler C; Lincoln J
J Cardiovasc Dev Dis; 2020 Aug; 7(3):. PubMed ID: 32824919
[TBL] [Abstract][Full Text] [Related]
6. Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome.
Gould RA; Sinha R; Aziz H; Rouf R; Dietz HC; Judge DP; Butcher J
PLoS One; 2012; 7(9):e44639. PubMed ID: 22984535
[TBL] [Abstract][Full Text] [Related]
7. Effects of Age, Sex, and Extracellular Matrix Integrity on Aortic Dilatation and Rupture in a Mouse Model of Marfan Syndrome.
Weiss D; Rego BV; Cavinato C; Li DS; Kawamura Y; Emuna N; Humphrey JD
Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):e358-e372. PubMed ID: 37470181
[TBL] [Abstract][Full Text] [Related]
8. IL11 (Interleukin-11) Causes Emphysematous Lung Disease in a Mouse Model of Marfan Syndrome.
Ng B; Xie C; Su L; Kuthubudeen FF; Kwek XY; Yeong D; Pua CJ; Cook SA; Lim WW
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):739-754. PubMed ID: 36924234
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.
Ng CM; Cheng A; Myers LA; Martinez-Murillo F; Jie C; Bedja D; Gabrielson KL; Hausladen JM; Mecham RP; Judge DP; Dietz HC
J Clin Invest; 2004 Dec; 114(11):1586-92. PubMed ID: 15546004
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
De Backer J
Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
[TBL] [Abstract][Full Text] [Related]
11. Early Impairment of Lung Mechanics in a Murine Model of Marfan Syndrome.
Uriarte JJ; Meirelles T; Gorbenko Del Blanco D; Nonaka PN; Campillo N; Sarri E; Navajas D; Egea G; Farré R
PLoS One; 2016; 11(3):e0152124. PubMed ID: 27003297
[TBL] [Abstract][Full Text] [Related]
12. Age and sex dependency of thoracic aortopathy in a mouse model of Marfan syndrome.
Gharraee N; Sun Y; Swisher JA; Lessner SM
Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H44-H56. PubMed ID: 34714692
[TBL] [Abstract][Full Text] [Related]
13. Mitral valve disease in Marfan syndrome and related disorders.
Judge DP; Rouf R; Habashi J; Dietz HC
J Cardiovasc Transl Res; 2011 Dec; 4(6):741-7. PubMed ID: 21866385
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic CCR2 Blockade Prevents Inflammation and Alleviates Myxomatous Valve Disease in Marfan Syndrome.
Xu N; Yutzey KE
JACC Basic Transl Sci; 2022 Nov; 7(11):1143-1157. PubMed ID: 36687269
[TBL] [Abstract][Full Text] [Related]
15. Male Marfan mice are predisposed to high-fat diet-induced obesity, diabetes, and fatty liver.
Tiedemann K; Muthu ML; Reinhardt DP; Komarova SV
Am J Physiol Cell Physiol; 2022 Aug; 323(2):C354-C366. PubMed ID: 35759435
[TBL] [Abstract][Full Text] [Related]
16. Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients.
Yin 殷晓科 X; Wanga S; Fellows AL; Barallobre-Barreiro J; Lu R; Davaapil H; Franken R; Fava M; Baig F; Skroblin P; Xing Q; Koolbergen DR; Groenink M; Zwinderman AH; Balm R; de Vries CJM; Mulder BJM; Viner R; Jahangiri M; Reinhardt DP; Sinha S; de Waard V; Mayr M
Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1859-1873. PubMed ID: 31315432
[TBL] [Abstract][Full Text] [Related]
17. Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes.
Tae HJ; Petrashevskaya N; Marshall S; Krawczyk M; Talan M
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H290-9. PubMed ID: 26566724
[TBL] [Abstract][Full Text] [Related]
18. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
19. Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.
Fisch S; Bachner-Hinenzon N; Ertracht O; Guo L; Arad Y; Ben-Zvi D; Liao R; Schneiderman J
J Am Heart Assoc; 2020 May; 9(10):e014761. PubMed ID: 32378446
[TBL] [Abstract][Full Text] [Related]
20. A nonsense variant in FBN1 caused autosomal dominant Marfan syndrome in a Chinese family: a case report.
Niu Y; Huang S; Wang Z; Xu P; Wang L; Li J; Gao M; Gao X; Gao Y
BMC Med Genet; 2020 Oct; 21(1):211. PubMed ID: 33087052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
